PPH vs IDNA

APPH

BIDNA

Measures won4–2PPH wins · of 6 · 5Y

$10,000 · 5Y$17,463PPH · IDNA $8,497

Lowest cost0.36%PPH · $36 on $10k

Most income1.76%PPH · $176 on $10k

Smallest drop−10.6%IDNA · worst fall in 1Y

Held in common3.4%PPH and IDNA

VanEck Pharmaceutical ETF · $1.1BiShares Genomics Immunology and Healthcare ETF · $340M

+18.6%3 years · per year$16,664 · $21,631+29.3%

+11.8%5 years · per year$17,463 · $8,497−3.2%

0.36%Expense ratio$36 · $47 on $10k · lower wins0.47%

1.76%12-mo yield$176 · $69 on $10k0.69%

End-of-day Nov 12, 2026 · $10,000 5 years ago, dividends reinvested · ● winner of the row · each row scaled to the bigger of the two

5Y2 funds

#			Trend
1	APPH	VanEck Pharmaceutical ETFRead Desk		0.36%	1.76%	−0.3%	+19.6%	+26.0%	+18.6%	+11.8%	−10.8%	$1.1B
2	BIDNA	iShares Genomics Immunology and Healthcare ETFRead Desk		0.47%	0.69%	−3.2%	+56.7%	+58.3%	+29.3%	−3.2%	−10.6%	$340M

End-of-day Nov 12, 2026 · total return, dividends in · 3Y and 5Y per year · A and B = the pair in versus

5Y2 funds

#			Trend
1	APPH	VanEck Pharmaceutical ETFRead Desk		0.36%	1.76%	−0.3%	+19.6%	+26.0%	+18.6%	+11.8%	−10.8%	$1.1B
2	BIDNA	iShares Genomics Immunology and Healthcare ETFRead Desk		0.47%	0.69%	−3.2%	+56.7%	+58.3%	+29.3%	−3.2%	−10.6%	$340M

End-of-day Nov 12, 2026 · total return, dividends in · 3Y and 5Y per year · A and B = the pair in versus

Cards for this view

PPH

VanEck Pharmaceutical

$17,463

IDNA

iShares Genomics Immunology and Healthcare

$8,497

Loading…